EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Interleukin‐11 receptor is an alternative α‐receptor for interleukin‐6 and the chimeric cytokine IC 7

Hendrik T Weitz, Julia Ettich, Puyan Rafii, Christoph Wittich, Laura Schultz, Nils C Frank, Denise Heise, Matthias Krusche, Juliane Lokau, Christoph Garbers iD, Kristina Behnke, Doreen M Floss and 3 more

The FEBS Journal · 2025

DOI: 10.1111/febs.17309 ↗

At a glance

Journal article in The FEBS Journal, 2025. Written by Hendrik T Weitz and 14 co-authors. Institution: Institute of Biochemistry and Molecular Biology II, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany. Major MEDLINE topics: Interleukin-6, Receptors, Interleukin-11, Interleukin-11 Receptor alpha Subunit. Cited 9 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: Deutsche Forschungsgemeinschaft.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The cytokine interleukin 6 (IL‐6) signals via the IL‐6 α‐receptor (IL‐6Rα or IL‐6R) in complex with the gp130 β‐receptor. Cell type restricted expression of the IL‐6R limits the action of IL‐6 mainly to hepatocytes and some immune cells. Here, we show that IL‐6 also binds to the IL‐11 α receptor (IL‐11Rα or IL‐11R) and induces signaling via IL‐11R:gp130 complexes, albeit with a lower affinity compared to IL‐11. Antagonistic antibodies directed against IL‐11R, but not IL‐6R, inhibit IL‐6 signaling via IL‐11R:gp130 receptor complexes. Notably, IL‐11 did not cross‐react with IL‐6R. IL‐11R has also been identified as an alternative α receptor for the CNTF/IL‐6‐derived chimeric cytokine IC7, which has recently been shown to induce weight loss in mice. Accordingly, the effects of therapeutic monoclonal antibodies against IL‐6 or IL‐6R, which both block IL‐6 signaling, may be slightly different. These findings provide new insights into IL‐6 signaling and therefore offer new potential therapeutic intervention options in the future.

Subjects

MeSH terms (MEDLINE)

Interleukin-6Receptors, Interleukin-11Interleukin-11 Receptor alpha SubunitHumansAnimalsSignal TransductionMiceCytokine Receptor gp130Interleukin-11Receptors, Interleukin-6Recombinant Fusion ProteinsHEK293 CellsProtein Binding

Author keywords

IL‐11cross‐talkcytokinegp130interleukin 6

Substances

Interleukin-6Cytokine Receptor gp130Interleukin-11Receptors, Interleukin-6Recombinant Fusion ProteinsReceptors, Interleukin-11Interleukin-11 Receptor alpha Subunit

Authors and institutions

  • Institute of Biochemistry and Molecular Biology II, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany.
  • Institute of Clinical Biochemistry, Hannover Medical School, Germany.
  • Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Germany.
  • Centre of Synthetic Biology, Technical University of Darmstadt, Germany.

ORCID profiles: Christoph Garbers, Harald Kolmar, Jürgen Scheller

Funding

  • Deutsche Forschungsgemeinschaft

Cite

APA

Weitz, H. T., Ettich, J., Rafii, P., Wittich, C., Schultz, L., Frank, N. C., Heise, D., Krusche, M., Lokau, J., Garbers, C., Behnke, K., Floss, D. M., Kolmar, H., Moll, J. M., & Scheller, J. (2025). Interleukin‐11 receptor is an alternative α‐receptor for interleukin‐6 and the chimeric cytokine IC 7. The FEBS Journal. https://doi.org/10.1111/febs.17309

Vancouver

Weitz HT, Ettich J, Rafii P, Wittich C, Schultz L, Frank NC, et al. Interleukin‐11 receptor is an alternative α‐receptor for interleukin‐6 and the chimeric cytokine IC 7. The FEBS Journal. 2025. doi:10.1111/febs.17309

BibTeX
@article{Weitz2025,
  author = {Weitz, Hendrik T and Ettich, Julia and Rafii, Puyan and Wittich, Christoph and Schultz, Laura and Frank, Nils C and Heise, Denise and Krusche, Matthias and Lokau, Juliane and Garbers, Christoph and Behnke, Kristina and Floss, Doreen M and Kolmar, Harald and Moll, Jens M and Scheller, Jürgen},
  title = {Interleukin‐11 receptor is an alternative α‐receptor for interleukin‐6 and the chimeric cytokine IC 7},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.17309}
}
Start for free →